The CASP3 Knockout MES-OV Polyclonal Cells product is a CRISPR/Cas9-edited polyclonal knockout cell population generated from the human ovarian carcinoma cell line MES-OV through disruption of the CASP3 gene. This heterogeneous pool of edited cells provides a robust loss-of-function model for studying CASP3-dependent apoptosis regulation. Supplied as a mixed knockout population, it allows immediate expansion and functional assays without clonal selection, capturing a range of mutations at the target locus. Researchers can leverage this system to investigate programmed cell death mechanisms in an epithelial tumor background.
The MES-OV host cell line is a well-established model of ovarian carcinoma, exhibiting epithelial characteristics and genomic features of high-grade serous ovarian cancer. These cells provide a physiologically relevant context for dissecting apoptotic signaling and drug responses, making them suitable for gene editing and functional studies. Their tumor origin and amenability to CRISPR/Cas9 manipulation enable the investigation of molecular mechanisms underlying ovarian cancer progression and therapy resistance in a disease-relevant system.
CASP3 encodes the executioner caspase central to both extrinsic and intrinsic apoptotic pathways. It is proteolytically activated by initiator caspases CASP8 and CASP9 following death receptor ligation or mitochondrial cytochrome c release, respectively. Activated CASP3 cleaves downstream substrates including PARP1, DFFA, ROCK1, GSN, and LMNA, dismantling cellular architecture. The protein functions within the apoptosome complex with APAF1 and cytochrome c, and its activity is modulated by inhibitors XIAP and BIRC5. Upstream regulators encompass FASLG, TNF, BCL2, BAX, and signal transduction via NF-??B and p53 pathways.
In ovarian carcinoma, CASP3 knockout provides a tool to dissect apoptosis resistance mechanisms prevalent in advanced tumors. Ablation of this executioner caspase in MES-OV cells disrupts terminal apoptotic machinery, enabling analysis of caspase-dependent and -independent cell death modalities. This model is valuable for studying evasion of chemotherapy-induced apoptosis, identification of alternative death pathways, and evaluation of upstream signaling dependencies on CASP8, CASP9, or BCL2 family proteins. It also aids in exploring non-apoptotic caspase functions within an ovarian cancer framework.
This knockout cell population supports diverse research applications including apoptosis mechanism studies, drug resistance screening, caspase inhibitor evaluation, and functional genomics of cell death. Assays such as western blotting for cleaved CASP3, PARP cleavage, caspase-3 activity, Annexin V flow cytometry, and TUNEL staining can be used. By comparing knockout and parental MES-OV cells, researchers can delineate CASP3-dependent phenotypes and validate downstream cleavage events. For further details, technical support, or customized solutions, please contact Ascent Research.
